Factor H is a regulatory protein of the alternate complement activation pat
hway. Factor H deficiency manifesting as permanent alternate pathway activa
tion has been reported in patients with hemolytic uremic syndrome (HUS), co
llagen III glomerulopathy, IgA nephropathy, systemic lupus erythematosus wi
th C2 deficiency, and membranoproliferative glomerulonephritis. Six pediatr
ic cases of factor H deficiency are reviewed. Three (cases 1-3), all boys,
presented with atypical HUS characterized by hemolytic anemia, severe hyper
tension, and progression to end-stage renal failure. Recurrent infections o
ccurred in cases 1 and 2, both of whom had repeatedly low factor H levels w
ith low C3 levels. Case 3 had C3 levels in the low-to-normal range and norm
al factor H levels with reduced factor H activity. Cases 4 and 5 were broth
ers born to consanguineous parents and presented with recurrent macroscopic
hematuria in the absence of significant proteinuria or renal function impa
irment. Renal biopsy demonstrated mesangial proliferation with dense C3 dep
osits in both cases. Case 6 was a 12-month-old girl presenting with macrosc
opic hematuria, nephrotic syndrome, anemia, and glomerular filtration rate
(GFR) reduction. Renal biopsy demonstrated proliferative crescentic glomeru
lonephritis with C3 deposits. Following a course of steroid therapy, protei
nuria decreased and both GFR and factor I-I returned to normal. These six c
ases illustrate the diversity of clinical and histological manifestations s
een in factor H-deficient patients. The exact pathogenic role of factor I-I
deficiency remains to be determined.